0 Canadian Stock Exchange News - November 13, 2018Graph Blockchain Announces Former IBM Senior Executive to Join the BoardTORONTO, Nov. 13, 2018 (GLOBE NEWSWIRE) — Graph Blockchain Inc. (“Graph” or “Company”) (CSE: GBLC) is very pleased to announce […]Read More
0 NYSE Companies - November 13, 2018Bonanza Creek Energy Appoints New Chief Financial OfficerDENVER, Nov. 13, 2018 (GLOBE NEWSWIRE) — Bonanza Creek Energy, Inc. (NYSE: BCEI) (“Bonanza Creek” or the “Company”) today announces the hiring […]Read More
0 NASDAQ Companies - November 13, 2018Establishment Labs Reports Third-Quarter 2018 Financial ResultsNEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) — Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on […]Read More
0 NASDAQ Companies - November 13, 2018Onconova Therapeutics Announces Business Highlights and Financial Results for Third Quarter 2018Conference Call Today at 9:00 a.m. Eastern Time NEWTOWN, Pa., Nov. 13, 2018 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (Nasdaq: […]Read More
0 NASDAQ Companies - November 13, 2018Oncolytics Biotech® Announces Attendance of Upcoming ConferencesCALGARY, Alberta and SAN DIEGO, Nov. 13, 2018 (GLOBE NEWSWIRE) — Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing […]Read More
0 NASDAQ Companies - November 13, 2018TBK Bank Announces Officer PromotionsDALLAS, Nov. 13, 2018 (GLOBE NEWSWIRE) — TBK Bank, SSB, a wholly owned subsidiary of Triumph Bancorp, Inc. (Nasdaq: TBK), […]Read More
0 NASDAQ Companies - November 13, 2018Aravive Presents Detailed Results of Phase 1 Clinical Trial of AVB-S6-500 at the 2018 EORTC-NCI-AACR SymposiumHOUSTON, Nov. 13, 2018 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company, today announced detailed results of […]Read More
0 NASDAQ Companies - November 13, 2018RedHill Biopharma Reports Third Quarter 2018 Financial Results and Business HighlightsKey Highlights: Top-line results from the confirmatory Phase III study with TALICIA® for H. pylori infection are on track to […]Read More
0 NASDAQ Companies - November 13, 2018Mersana Therapeutics Announces Third Quarter 2018 Financial Results and Provides Business UpdatesXMT-1536 Phase 1 Dose Escalation Ongoing with Data Expected in the First Half of 2019 XMT-1522 Phase 1 Dose Escalation […]Read More
0 NASDAQ Companies - November 13, 2018Solid Biosciences Reports Third Quarter 2018 Financial Results And Provides Business UpdateTwo Additional Patients Dosed With SGT-001 Gene Transfer in IGNITE DMD Clinical Trial Company Plans to Report Preliminary Results from […]Read More